Guided Therapeutics (GTHP) Other Non Operating Income (2013 - 2026)
Guided Therapeutics (GTHP) posted Other Non Operating Income of -$579000.0 for Q4 2025, down 446.23% sequentially from -$106000.0 in Q3 2025, and down 87.38% YoY from -$4.6 million in Q4 2024.
Guided Therapeutics (GTHP) Other Non Operating Income (2013 - 2026) Analysis & Trends
Guided Therapeutics has reported Other Non Operating Income for 13 years, with the latest figure at -$579000.0 in Q4 2025.
- Quarterly Other Non Operating Income fell 87.38% year-over-year to -$579000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$523000.0 (down 30.42% YoY) and the FY2025 annual result came in at -$533000.0, down 72.49% from the prior year.
- Other Non Operating Income retreated to -$579000.0 in Q4 2025 per GTHP's latest filing, from -$106000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $555000.0 in Q3 2021 and troughed at -$579000.0 in Q4 2025.
- A 5-year average of -$60388.9 and a median of $1000.0 in 2022 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income plunged 930.0% in 2024, then jumped 9700.0% in 2025.
- Over 5 years, Other Non Operating Income stood at -$286000.0 in 2021, then jumped by 103.85% to $11000.0 in 2022, then tumbled by 372.73% to -$30000.0 in 2023, then slumped by 930.0% to -$309000.0 in 2024, then slumped by 87.38% to -$579000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$579000.0, -$106000.0, and $64000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -127,000.00 |
| Dec 31, 2025 | -579,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | -309,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -30,000.00 |
| Sep 30, 2023 | 17,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -64,000.00 |
| Dec 31, 2021 | -286,000.00 |
| Sep 30, 2021 | 555,000.00 |
| Jun 30, 2021 | -473,000.00 |
| Mar 31, 2021 | 87,000.00 |
| Dec 31, 2020 | 2.37 Mn |